ANI Pharmaceuticals, Inc. (ANIP)
USD 53.88
(-3.49%)
USD 53.88
(-3.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 118.95 Million | -31.2 Million | 3.32 Million | 15.26 Million | 45.63 Million | 67.07 Million |
| Net Income | 18.77 Million | -47.89 Million | -42.6 Million | -22.54 Million | 6.09 Million | 15.49 Million |
| Depreciation & Amortization | 59.79 Million | 59.65 Million | 47.25 Million | 44.63 Million | 44.61 Million | 33.74 Million |
| Deferred income taxes | -11.74 Million | -15.25 Million | -16.75 Million | -13.2 Million | -9.13 Million | -5.18 Million |
| Stock-based compensation | 20.65 Million | 14.59 Million | 10.48 Million | 12.93 Million | 9.21 Million | 6.78 Million |
| Change in working capital | 24.86 Million | -51.3 Million | -84 Thousand | -12.62 Million | -14.58 Million | 5.96 Million |
| Other non-cash items | 6.61 Million | 8.99 Million | 5.02 Million | 6.07 Million | 9.42 Million | 10.26 Million |
| Investing Cash Flow | -18.51 Million | -15.73 Million | -105.48 Million | -68.32 Million | -27.54 Million | -27.37 Million |
| Investments in PPE | -18.51 Million | -16.45 Million | -23.63 Million | -68.32 Million | -27.54 Million | -10.91 Million |
| Acquisitions | - | -33 Thousand | -84.49 Million | - | - | -16.46 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9.64 Million | 750 Thousand | 2.64 Million | -62.18 Million | -20.91 Million | -5.16 Million |
| Financing Cash Flow | 67.43 Million | -5.12 Million | 194.59 Million | -1.43 Million | 1.25 Million | -27.81 Million |
| Debt repayment | -3 Million | -3 Million | -211.01 Million | -15.53 Million | -121.45 Million | -2.81 Million |
| Dividends payments | -1.62 Million | -1.62 Million | -190 Thousand | - | - | - |
| Common Stock Repurchased | -4.98 Million | -1.95 Million | -890 Thousand | -1.52 Million | -1.03 Million | -659 Thousand |
| Common Stock Issuance | 89.55 Million | 1.45 Million | 75 Million | 618 Thousand | 5.73 Million | 2.97 Million |
| Other Financing Activities | -12.5 Million | -3.5 Million | 331.68 Million | 15.61 Million | 123.73 Million | -24.34 Million |
| Accounts receivables | 3.35 Million | -36.91 Million | -5.54 Million | -23.66 Million | -7.28 Million | -4.74 Million |
| Accounts payables | 7.55 Million | 5.03 Million | 10.16 Million | -2.29 Million | 5.03 Million | 3.46 Million |
| Inventory | -5.84 Million | -23.62 Million | 3.22 Million | -2.75 Million | -7.66 Million | -379 Thousand |
| Other working capital | 19.79 Million | 4.2 Million | -7.92 Million | 16.08 Million | -4.67 Million | 7.62 Million |
| Cash at beginning of period | 53.23 Million | 105.3 Million | 12.86 Million | 67.36 Million | 48.02 Million | 36.15 Million |
| Cash at end of period | 221.12 Million | 53.23 Million | 105.3 Million | 12.86 Million | 67.36 Million | 48.02 Million |
| Capital Expenditure | -18.51 Million | -16.45 Million | -23.63 Million | -68.32 Million | -27.54 Million | -10.91 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 167.88 Million | -52.06 Million | 92.43 Million | -54.49 Million | 19.33 Million | 11.87 Million |
| Free Cash Flow | 100.44 Million | -47.65 Million | -20.31 Million | -53.05 Million | 18.08 Million | 56.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.28 Million | 16.4 Million | 1.15 Million | 18.77 Million | 9.94 Million | 6.24 Million |
| Depreciation & Amortization | 14.69 Million | 14.68 Million | 15.19 Million | 59.79 Million | 15.2 Million | 14.69 Million |
| Deferred income taxes | -1.89 Million | 3.1 Million | -8.34 Million | -11.74 Million | -3.25 Million | -910 Thousand |
| Stock-based compensation | 7.86 Million | 6.93 Million | 5.62 Million | 20.65 Million | 5.44 Million | 5.24 Million |
| Change in working capital | -4.5 Million | -10.22 Million | 27.79 Million | 24.86 Million | 5.56 Million | -6.73 Million |
| Other non-cash items | 47.23 Million | 25.12 Million | 3.31 Million | 6.61 Million | -731 Thousand | 2.08 Million |
| Investing Cash Flow | -4.44 Million | 8.93 Million | -4.77 Million | -18.51 Million | -4.55 Million | -6.82 Million |
| Investments in PPE | -4.44 Million | -4.58 Million | -4.77 Million | -18.51 Million | -4.55 Million | -6.82 Million |
| Acquisitions | - | 13.51 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 7.71 Million | -2.5 Million | -9.64 Million | -2.81 Million | -4.32 Million |
| Financing Cash Flow | -1.45 Million | -19.72 Million | -11.91 Million | 67.43 Million | 3.75 Million | 80.15 Million |
| Debt repayment | -750 Thousand | -750 Thousand | -750 Thousand | -3 Million | -750 Thousand | -750 Thousand |
| Dividends payments | -407 Thousand | -406 Thousand | -406 Thousand | -1.62 Million | -406 Thousand | -407 Thousand |
| Common Stock Repurchased | -1.3 Million | -8.66 Million | -231 Thousand | -4.98 Million | -670 Thousand | -537 Thousand |
| Common Stock Issuance | 1 Million | 2.59 Million | 1.96 Million | 89.55 Million | 5.58 Million | 81.84 Million |
| Other Financing Activities | 1 Million | -12.5 Million | -12.5 Million | -12.5 Million | 4.16 Million | 80.55 Million |
| Accounts receivables | 6.32 Million | -10.33 Million | 16.76 Million | 3.35 Million | -5.91 Million | 1.78 Million |
| Accounts payables | -1.14 Million | 11.52 Million | 2.78 Million | 7.55 Million | 5.57 Million | -3.9 Million |
| Inventory | -11.61 Million | -2.64 Million | -4.6 Million | -5.84 Million | -2.26 Million | -669 Thousand |
| Other working capital | 1.92 Million | -8.77 Million | 12.86 Million | 19.79 Million | 8.18 Million | -3.94 Million |
| Cash at beginning of period | 228.59 Million | 221.12 Million | 193.07 Million | 53.23 Million | 161.7 Million | 67.75 Million |
| Cash at end of period | 240.11 Million | 228.59 Million | 221.12 Million | 221.12 Million | 193.07 Million | 161.7 Million |
| Capital Expenditure | -4.44 Million | -4.58 Million | -4.77 Million | -18.51 Million | -4.55 Million | -6.82 Million |
| Effect of forex changes on cash | - | - | -6.47 Million | - | - | -80.18 Million |
| Net cash flow / Change in cash | 11.51 Million | 7.47 Million | 28.04 Million | 167.88 Million | 31.37 Million | 93.95 Million |
| Free Cash Flow | 12.96 Million | 13.68 Million | 39.96 Million | 100.44 Million | 27.61 Million | 13.8 Million |
NVS
AKEJF
SMREF
0IPY
CNM
3930